Big market research adds a report titled World Anti-Inflammatory Therapeutics - Market Opportunities and Forecasts, 2014 - 2020). As per the report, global anti-inflammatory therapeutics market would grow at 5.9% CAGR amid the forecast period. The report
Increasing autoimmune and respiratory conditions, new drugs being invented, increasing awareness of anti-inflammatory therapeutics and attractive government initiatives in the Asia-Pacific and LAMEA region are the prominent reasons driving the global anti-inflammatory therapeutics market. The report enumerates various attractive government initiatives in the Asia-Pacific and LAMEA region which offers impetus to the growth of the market in the aforementioned regions. The report exhaustive analysis of the market dynamics in terms of key drivers and restraints, current and future market trends, detailed segmentation and forecast and business profile of key market players along with their strategies and the tactical moves to grow in the market.
The report also offers quantitative analysis of the current market conditions by offering useful and relevant data on the market share and forecast of the various segments which help the market investors in identifying the lucrative market opportunities. The report further offers an insight into competitive business intelligence of major manufacturers and distributors of anti-inflammatory industry globally. Further the report highlights the market challenges in the form of doing away with the side effects of anti-inflammatory drugs and issues related to patent expiry of blockbuster drugs and how the leading vendors and investors will devise strategies to overcome these challenges. The report covers the major geographical regions such as North America, Asia-Pacific, Europe, and LAMEA.
Key market players profiled in this report are:
Pfizer, Inc., Johnson & Johnson , Abbvie, Inc., , GlaxoSmithKline, Novartis, Merck & CO., Inc., La Roche AG , F. Hoffman, Eli Lily and Company, Amgen, and AstraZeneca PLC.
5933 NE Win Sivers Drive,
#205, Portland, OR 97220
Direct :+ 1-503-894-6022
Toll Free :+ 1-800-910-6452
Fax : +1 (855) 550-5975